Q1 2026 Draegerwerk AG & Co KGaA Earnings Call Transcript
Key Points
- Order intake rose to around EUR865 million, indicating strong demand.
- Net sales increased to approximately EUR756 million, marking a return to growth.
- EBIT increased significantly to roughly EUR18 million, improving the EBIT margin to 2.4%.
- Free cash flow rose considerably to more than EUR44 million, reflecting strong earnings performance.
- The company proposed a higher dividend for the third consecutive year, showcasing improved profitability.
- APAC region experienced a slight decline in net sales, impacting overall growth.
- Gross margin in the Safety division fell by 1.4 percentage points due to product mix and currency effects.
- Financial expenses rose by around 3%, driven by higher personnel expenses.
- The Medical division's EBIT, although improved, remained negative at minus EUR18.5 million.
- Substantial base effects on order entry are expected in Q2, potentially affecting future growth comparisons.
Ladies and gentlemen, welcome to the Drägerwerk Q1 2026 earnings call. I am Sandra, the Chorus Call operator. I would like to remind you that all participants have been in listen-only mode, and the conference is being recorded. The presentation will be followed by a Q&A session. (Operator instructions) The conference must not be recorded for publication or broadcast.
At this time, it is my pleasure to hand over to Stefan Dräger, CEO. Please go ahead, sir.
Hello. Good afternoon, and thank you for joining our conference call and our financial results for the first three months of 2026. I have with me today Gert-Hartwing Lescow, CFO; as well as Tom Fischler and Nikolaus Hammerschmidt, both Investor Relations.
We would like to take you through the results of the presentation that we made available on our web page this morning. Following the presentation, we will open the floor to your questions.
Let's get started on page 5 with the business highlights.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
